M K Proteins Limited · NSE:MKPL
M K Proteins Limited financial statements
M K Proteins Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.83B | 2.68B | 2.46B | 3.15B | 2.56B | 3.11B | 1.94B | 1.57B | 1.72B | 1.65B |
| Cost of revenue | 3.68B | 2.53B | 2.26B | 2.97B | 2.37B | 2.92B | 1.87B | 1.50B | 1.64B | 1.57B |
| Gross profit | 144.5M | 156.5M | 192.9M | 180.6M | 186.8M | 186.2M | 71.3M | 67.7M | 79.9M | 78.4M |
| Selling, general and administrative | 4.81M | 27.5M | 27.9M | 889.0K | 844.2K | 960.2K | 621.8K | 981.3K | 17.7M | 372.8K |
| Operating income | 109.8M | 129.1M | 165.2M | 169.2M | 148.3M | 151.0M | 36.5M | 37.9M | 62.2M | 36.6M |
| Depreciation and amortization | 4.36M | 3.52M | 5.28M | 8.20M | 9.15M | 9.09M | 11.7M | 12.2M | 12.2M | 12.1M |
| EBITDA | 114.2M | 132.6M | 170.4M | 177.4M | 157.4M | 160.1M | 48.2M | 50.1M | 74.4M | 48.8M |
| Interest expense | 18.5M | 11.1M | 11.2M | 19.0M | 8.88M | 8.25M | 15.2M | 15.4M | 22.0M | 22.0M |
| Income before tax | 93.9M | 114.5M | 154.7M | 149.9M | 140.4M | 143.2M | 24.4M | 22.9M | 22.0M | 15.1M |
| Income tax | 25.6M | 30.5M | 42.6M | 40.6M | 38.6M | 39.3M | 6.26M | 6.42M | 7.77M | 5.27M |
| Net income | 68.3M | 84.0M | 112.1M | 109.3M | 101.8M | 103.9M | 18.2M | 16.4M | 14.3M | 9.86M |
| Earnings per share, basic | 0.18 | 0.22 | 0.30 | 0.29 | 0.27 | 0.28 | 0.05 | 0.04 | 0.04 | 0.04 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.38M | 338.0K | 923.2K | 624.8K | 66.6K | 12.6K | 1.15M | 41.5K | 2.03M | 350.4K |
| Receivables | 21.1M | 14.0M | 35.7M | 160.6M | 310.2M | 201.8M | 107.3M | 108.4M | 185.2M | 45.9M |
| Inventory | 1.10B | 1.11B | 792.7M | 809.1M | 497.7M | 377.0M | 389.9M | 293.5M | 300.2M | 333.2M |
| Current assets | 1.18B | 1.19B | 858.4M | 985.8M | 823.1M | 642.0M | 528.4M | 423.8M | 498.6M | 389.3M |
| Total assets | 1.31B | 1.31B | 962.5M | 1.03B | 861.5M | 673.5M | 565.5M | 472.6M | 561.0M | 465.7M |
| Accounts payable | 50.4M | 193.1M | 114.9M | 48.0M | 50.3M | 80.4M | 37.3M | 24.8M | 52.3M | 94.3M |
| Current liabilities | 525.4M | 590.0M | 339.6M | 496.3M | 438.1M | 335.1M | 335.9M | 285.6M | 288.4M | 299.7M |
| Long-term debt | 10.5M | 8.30M | 0 | 25.4M | 26.5M | |||||
| Total debt | 371.4M | 387.2M | 200.8M | 455.3M | 367.8M | 251.3M | 305.7M | 261.6M | 329.8M | 313.0M |
| Total liabilities | 549.0M | 611.0M | 351.7M | 533.6M | 465.4M | 380.1M | 376.0M | 301.2M | 406.0M | 423.1M |
| Shareholders' equity | 763.0M | 694.7M | 610.8M | 498.6M | 396.0M | 293.4M | 189.5M | 171.4M | 155.0M | 42.6M |
| Shares outstanding | 379.4M | 381.7M | 375.4M | 375.4M | 375.4M | 375.3M | 375.4M | 380.1M | 375.4M | 243.8M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 38.1M | -161.3M | 324.2M | -58.7M | -101.2M | 55.4M | -44.7M | 63.5M | -120.2M | -35.8M |
| Capital spending | -19.0M | -22.2M | -59.0M | -72.1K | -15.7M | -2.59M | -318.5K | -1.59M | 0 | -10.2M |
| Free cash flow | 19.1M | -183.5M | 265.1M | -58.8M | -116.9M | 52.8M | -45.0M | 61.9M | -120.2M | -46.1M |
| Cash from investing | -17.2M | -14.8M | -58.8M | 133.8K | -15.3M | -2.11M | 1.75M | 2.70M | -740.7K | -13.6M |
| Cash from financing | -16.8M | 175.5M | -265.1M | 59.2M | 116.6M | -54.4M | 44.0M | -68.2M | 122.6M | 45.8M |
| Change in cash | 4.04M | -585.0K | 298.4K | 558.2K | 54.1K | -1.14M | 1.11M | -1.99M | 1.68M | -3.64M |